Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies. Athersys, California Stem Cell Inc., and Cytori Therapeutics Inc. are engaged in the development of novel stem cell therapies from cord blood. Ethical issues regarding cord blood sample application is creating biasness among donor, which is majorly influencing the market.
Competition is currently intense with companies trying to create brand awareness. This is therefore, compelling the market players to formulate market based strategies. Cord blood stem cell is the only type of stem cell that is stored in controlled condition due to its lower volume higher cell count feature. Storage service market is expected grow at 33.4% CAGR from 2013-2020.
This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market
Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision
Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report
Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions
SWOT analysis and strategic developments included in the report for Key players: Advanced Cell Technology, Inc. (USA), Athersys, California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast, Opexa Therapeutics Geron Corporation, Neostem Inc.
KEY MARKET SEGMENTS
GLOBAL MARKET, BY STORAGE
Public cord blood banks
Private cord blood banks
Public Vs. Private UCB banks
GLOBAL MARKET, BY DISEASES
Cancer/ Oncology diseases
High Risk Solid Tumors
Sickle Cell disease
Leukocyte Adhesion Deficiency
GLOBAL MARKET BY, TECHNOLOGY
Stem Cell Transplant
Cord Blood Banking
Cell Based Genetics
GLOBAL MARKET, BY GEOGRAPHY
UCB market in North America
UCB market in Europe
UCB market in Asia-pacific
UCB market in ROW
Therapeutics service companies
Private and government research institutes
Research based pharmaceutical companies
Public and Private cord blood banks
Cord blood stem cell collection is much easier way of obtaining stem cell as compared to other stem cells such as Bone Marrow. Minimal invasive technique in stem cell collection and transferring is yet to saturate as this market is emerging in therapeutics. Minimal invasive techniques are available for collection of cord blood however; there is need to conduct some surgical operation in transferring of stem cells. These techniques are expected to become non-invasive in future.
This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.
Internet of things (IoT), comprising components such as devices, network connectivity, electronics system and software, is basically the networking of connected devices or things to transmit the data between them without human intervention.
High prevalence of chronic diseases and growing healthcare awareness has boosted the market growth for neuroprosthetic devices/implants. This research report provides pin-point analysis of the global neuroprosthetics market, including market estimates and trends through 2020. The report contains an in-depth analysis of different segments such as neuroprosthetics technologies, types, applications and geography.
Catheterization is type of co-procedure performed along with varied medical procedures including, angioplasty, cardiac electrophysiology, neurological surgery among others. The global catheters market is primarily driven by the increasing prevalence of cardiovascular diseases along with the increasing demand for minimal invasive surgeries. The demand for the catheters market is also fueled by the rising incidences of diabetes, cardiovascular diseases, urinary bladder failure, and kidney failure.
Intravenous Immunoglobulin (IVIG) is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases.
Increased investments, governments providing funds and grants, rising collaborations and research-related activities, technological innovations, widening of biomaterial applications in medical device market, and rise in ageing population are the major factors that are expected to drive the market globally. Additionally, the global medical devices market is projected to reach over $230.0 billion by 2020, with a CAGR of 6.8% from 2013 to 2020, which will also propel the growth of biomaterials with respect to the medical devices market.
Drugs that are administered by patients themselves are known as self-administered drugs. These drugs can be taken through implantable and non-implantable infusion pumps that come in contact with the skin surface. OTC, Oral and Topical preparations are also considered self-administered drugs. Active lifestyles have prompted patients to seek drugs that would not only save time, but would enable them to avoid hospitals altogether (except in emergency cases).
Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost bodys natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering
Spine surgery devices are used in surgeries performed for treatment of spinal cord disorders, trauma, bleeding, tumors and others. These devices are used for the treatment of spinal disorders, such as spinal stenosis, cervical discopathy, spondylolisthesis, spinal fractures, scoliosis, and kyphosis. It aids in performing complex spinal implant surgeries with accuracy and precision.